AB018. Evaluation of nivolumab as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC)

BACKGROUND: Lung cancer has recently emerged as a key objective of immunotherapies. Several patients with advanced lung cancer have benefitted significantly, demonstrating prolonged remissions of the disease and prolongation of survival while the treatment toxicity is reduced. The purpose of the stu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Nikolakopoulou, Asimina, Tzimopoulos, Kon/nos, Kerasiotis, Haralambos, Kallianos, Anastasios, Kavvada, Catherine, Gkartzonika, Helen, Tsarouha, Emilia, Rapti, Angeliki
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Abstract
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159350/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados